A detailed history of Stone Run Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Stone Run Capital, LLC holds 1,670 shares of JNJ stock, worth $267,417. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,670
Previous 1,670 -0.0%
Holding current value
$267,417
Previous $264 Million 7.6%
% of portfolio
0.1%
Previous 0.1%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $109,200 - $119,160
-750 Reduced 30.99%
1,670 $262 Million
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $376,915 - $422,241
2,420 New
2,420 $377 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $16,819 - $18,601
-100 Reduced 3.71%
2,594 $460,000
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $8,732 - $9,688
-56 Reduced 2.04%
2,694 $461,000
Q1 2018

May 14, 2018

SELL
$125.1 - $148.14 $31,275 - $37,035
-250 Reduced 8.33%
2,750 $352,000
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $388,410 - $406,140
3,000
3,000 $390,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $419B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Stone Run Capital, LLC Portfolio

Follow Stone Run Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Run Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone Run Capital, LLC with notifications on news.